Symbiotec Pharmalab IPO opens for investors
A pharmaceutical company named Symbiotec Pharmalab is offering shares to the public so people can buy a small piece of the business. The share price is set between 938 and 988 rupees.
What happened
Symbiotec Pharmalab, a company that makes medicines and medical products, is starting a stock market offering known as an IPO. An IPO means Initial Public Offering, which is when a private company invites everyday people and big financial groups to buy shares of ownership in their business. The company set its price range between 938 and 988 rupees for each share.
Key dates and details
People who want to buy shares can start placing their orders on August 24. The bidding window will stay open for a few days and close on August 27. The company set aside specific amounts of shares for different types of buyers, including regular everyday investors and large financial institutions. The final stock market listing is planned for September 1.
What happens next
- Investors can apply for shares starting August 24.
- The bidding process will close on August 27.
- Company shares will officially start trading on the stock exchange on September 1.